- Home
- NRIX vs SYBT Comparison
NRIX vs SYBT Comparison
Compare NRIX & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | SYBT |
|---|---|---|
| Founded | 2009 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | NRIX | SYBT |
|---|---|---|
| Price | $23.40 | $77.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $33.93 | ★ $90.20 |
| AVG Volume (30 Days) | ★ 1.2M | 121.8K |
| Earning Date | 10-08-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.71% |
| EPS Growth | N/A | ★ 22.11 |
| EPS | N/A | ★ 2.55 |
| Revenue | ★ $76,987,000.00 | $23,406,000.00 |
| Revenue This Year | $799.42 | $15.13 |
| Revenue Next Year | N/A | $8.33 |
| P/E Ratio | ★ N/A | $30.24 |
| Revenue Growth | ★ 99.31 | 3.37 |
| 52 Week Low | $9.00 | $61.51 |
| 52 Week High | $28.23 | $89.22 |
Technical Indicators
Market Signals| Indicator | NRIX | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 35.44 |
| Support Level | $22.56 | $74.73 |
| Resistance Level | $24.98 | $82.14 |
| Average True Range (ATR) | 0.92 | 1.73 |
| MACD | -0.18 | -0.18 |
| Stochastic Oscillator | 37.56 | 2.77 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.